Tensec | $12,000,000 | (Jun 19, 2025)
Grifin | $11,000,000 | (Jun 19, 2025)
Materna Medical | $20,000,000 | (Jun 19, 2025)
Certified by Founder
Lodge
DalCor Pharmaceuticals
start up
Canada
- Montreal, Québec
- 22/09/2023
- Series D
- $80,000,000
DalCor Pharmaceuticals: DalCor Pharmaceuticals is pioneering precision medicine for patients with cardiovascular disease. By combining genetic and clinical insights, the company’s development program, dalcetrapib, is intended to reduce fatal and non-fatal myocardial infarction (MI) following a recent acute coronary syndrome and deliver superior cardiovascular outcome in a specific genetic subset of patients.
- Industry Biotechnology Research
- Website https://dalcorpharma.com/
- LinkedIn https://www.linkedin.com/company/dalcor-pharmaceuticals/about/
NaroIQ | $6,500,000 | (Jun 19, 2025)
Polar | $9,860,072 | (Jun 19, 2025)
Darwix AI | $1,500,000 | (Jun 19, 2025)
Infinity Bio, Inc. | $8,000,000 | (Jun 19, 2025)
HydroBlok | $6,000,000 | (Jun 19, 2025)
Orange Quantum Systems | $13,742,820 | (Jun 19, 2025)
Corvia Medical, Inc. | $55,000,000 | (Jun 18, 2025)
GetZoot | $6,000,000 | (Jun 18, 2025)
AthenaHQ | $2,200,000 | (Jun 18, 2025)